tirzepatide retatrutide Buy in the UK Tirzepatide vs. Retatrutide: Key Differences

Let's find out

Professional opportunities disappear

Serious but Rare Side Effects Both medications carry warnings for more serious but uncommon side effects, occurring in less than 1-2% of patients: Pancreatitis (inflammation of the pancreas) Kidney problems Severe allergic reactions Thyroid tumors (seen in animal studies) Gastroparesis (delayed stomach emptying) Serious stomach issues Vision problems in some diabetics Retatrutides side effect profile appears similar to that of other incretin-based medications, though long-term safety data remains limited due to its investigational status

One of the first studies that investigated the influence of gut hormones on WR after RYGB was conducted by Santo in 2016 [56], and a difference in the secretion of gut hormones were observed between patients with WR and those with weight loss after RYGB

When to speak to your GP or oncologist Contact your GP, prescriber, or oncology team if you experience: Any new lumps, changes in the affected or unaffected breast, or new symptoms that prompt concern about recurrence Persistent nausea or vomiting that stops you from keeping fluids down Rapid or significant weight loss beyond whats expected Signs of dehydration (dark urine, dizziness, reduced urination) New fatigue that feels different from your post-treatment fatigue Worsening joint pain or new bone pain Increasing anxiety, low mood, or fear of recurrence thats affecting daily life Any difficulty attending cancer follow-up appointments because of side effects Dont delay routine cancer surveillance because of Wegovy